Similarly, the knockdown of SPARC attenuated the TGF-β1-induced aromatase protein levels in primary hGL cells derived from both non-OHSS and OHSS patients (Fig. 8C and D). This evidence concerns the gene CYP19A1 and ovarian hyperstimulation syndrome.